Skip to main content

Animations

MJFF Publications

1141 - 1150 of 8587 Results
Title
Year
  • Year
  • 2020
  • 2018
  • 2017
  • 2018
  • 2019
  • 2021
  • 2023
  • 2016
  • 2015
  • 2023
  • Summary Details
    RESTRICTED
    Title: The Accumulation of Tau in Postsynaptic Structures: A Common Feature in Multiple Neurodegenerative Diseases?
    Journal Name: The Neuroscientist
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1177/1073858420916696
    Citation Count: 18
  • Summary Details
    RESTRICTED
    Title: Finding useful biomarkers for Parkinson’s disease
    Journal Name: Science Translational Medicine
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1126/scitranslmed.aam6003
    Citation Count: 119
  • Summary Details
    RESTRICTED
    Title: Alpha-synuclein oligomers: a new hope
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00401-017-1755-1
    Citation Count: 255
  • Summary Details
    RESTRICTED
    Title: Renewed assessment of the risk of emergent advanced cell therapies to transmit neuroproteinopathies
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00401-018-1941-9
    Citation Count: 6
  • Summary Details
    RESTRICTED
    Title: Selective vulnerability in α-synucleinopathies
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00401-019-02010-2
    Citation Count: 59
  • Summary Details
    RESTRICTED
    Title: Periphery and brain, innate and adaptive immunity in Parkinson’s disease
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00401-021-02268-5
    Citation Count: 147
  • Summary Details
    RESTRICTED
    Title: Biomarkers for parkinsonian disorders in CNS-originating EVs: promise and challenges
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00401-023-02557-1
    Citation Count: 22
  • Summary Details
    RESTRICTED
    Title: Epigenetic regulation in Parkinson’s disease
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s00401-016-1590-9
    Citation Count: 84
  • Summary Details
    RESTRICTED
    Title: Neuroimaging of Freezing of Gait
    Journal Name: Journal of Parkinson's Disease
    Publisher: IOS Press
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.3233/jpd-150536
    Citation Count: 90
  • Summary Details
    RESTRICTED
    Title: Establishing an online resource to facilitate global collaboration and inclusion of underrepresented populations: Experience from the MJFF Global Genetic Parkinson’s Disease Project
    Journal Name: PLOS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0292180
    Citation Count: 0
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.